Source:http://linkedlifedata.com/resource/lhgdn/association:20018
| Predicate | Object |
|---|---|
| lhgdn:found_in | |
| lhgdn:geneRifSource |
MDM2 amplification in soft tissue sarcoma patients was associated with a prognosis better than that of patients without the amplification.of the tumors with an MDM2 amplification, 40% also experienced loss of heterozygosity at 12q14-15.
|
| lhgdn:mesh_code |
D012509
|
| lhgdn:associationIdType | |
| lhgdn:umls_code |